Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients

Trial ID or NCT#

NCT00568282

Status

not recruiting iconNOT RECRUITING

Purpose

The primary aim of this study is to determine whether we can identify human lung cancer tumor cells in the peripheral blood of lung cancer patients.

Official Title

Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients (Old Title: Significance of CD44 and or Epithelial Specific Antigen Positive Cells in the Peripheral Blood of Lung Cancer Patients) (LUN0017)

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Show Less

Investigator(s)

Heather Wakelee
Heather Wakelee
Medical oncologist, Thoracic specialist
Winston Chen and Phyllis Huang Professor
Shan X. Wang
Joel Neal, MD, PhD
Joel Neal, MD, PhD
Medical oncologist, Thoracic specialist
Professor of Medicine (Oncology)
Rajat Rohatgi

Contact us to find out if this trial is right for you.

Contact

Lisa Zhou
650-736-4112

View on ClinicalTrials.gov